AU3023999A - Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate - Google Patents

Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate

Info

Publication number
AU3023999A
AU3023999A AU30239/99A AU3023999A AU3023999A AU 3023999 A AU3023999 A AU 3023999A AU 30239/99 A AU30239/99 A AU 30239/99A AU 3023999 A AU3023999 A AU 3023999A AU 3023999 A AU3023999 A AU 3023999A
Authority
AU
Australia
Prior art keywords
human
diphenylchromans
sub
manufacture
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30239/99A
Inventor
Birgitte Hjort Guldhammer
Niels Korsgaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU3023999A publication Critical patent/AU3023999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU30239/99A 1998-03-20 1999-03-17 Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate Abandoned AU3023999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK394/98 1998-03-20
DK39498 1998-03-20
PCT/DK1999/000139 WO1999048497A1 (en) 1998-03-20 1999-03-17 USE OF 3,4-DIPHENYLCHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR LOWERING PLASMA LEVELS OF Lp(a) IN A HUMAN OR SUB-HUMAN PRIMATE

Publications (1)

Publication Number Publication Date
AU3023999A true AU3023999A (en) 1999-10-18

Family

ID=8093022

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30239/99A Abandoned AU3023999A (en) 1998-03-20 1999-03-17 Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate

Country Status (2)

Country Link
AU (1) AU3023999A (en)
WO (1) WO1999048497A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
WO1996021443A1 (en) * 1995-01-13 1996-07-18 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment

Also Published As

Publication number Publication date
WO1999048497A1 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
AU1450900A (en) Methods of treatment of type 2 diabetes
AU2480499A (en) Calcification-resistant medical articles
AU2317699A (en) Dental restoratives
AU4060599A (en) Pharmaceutical composition for treating or preventing sleep disorders
AUPP370198A0 (en) Control of the administration of continuous positive airway pressure treatment
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU1818100A (en) Desktop projection monitor
AU5732699A (en) Corneal onlay
AU2001284413A1 (en) Medicinal compositions for preventing or treating heart failure
AU1367597A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy
IL139531A0 (en) Human antithrombin iii, methods for the production thereof and pharmaceutical compositions containing the same
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
AU768217C (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same
AU4328996A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
AUPP332898A0 (en) Pharmaceutical composition
AU3059795A (en) Cosmetic composition which prevents or attenuates the photo-reactivity of titanium dioxide nanopigments
AU3023999A (en) Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate
AU5055799A (en) Dermatological compositions for the treatment of scars
AU4329196A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
AU4329096A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia
AU4107797A (en) Compounds for the treatment and prevention of diabetes
HRP20020047B1 (en) sTREPTOGRAMIN DERIVATIVES, PRODUCTION THEREOF AND COMPOSITIONS CONTAINING THE SAME
AU3171099A (en) 1-heteroindene derivatives and medicinal composition containing the same
AU4475300A (en) Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression
AU4546699A (en) Stabilized carbon dioxide fluid composition and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase